Trecarichi, Enrico Maria
 Distribuzione geografica
Continente #
EU - Europa 3909
NA - Nord America 1713
AS - Asia 1128
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 9
AF - Africa 7
OC - Oceania 3
Totale 6780
Nazione #
DE - Germania 2445
US - Stati Uniti d'America 1698
CN - Cina 971
SE - Svezia 408
UA - Ucraina 289
GB - Regno Unito 214
IT - Italia 208
FR - Francia 148
TR - Turchia 79
FI - Finlandia 67
PL - Polonia 60
IN - India 49
CA - Canada 13
NL - Olanda 13
BE - Belgio 11
RO - Romania 10
RU - Federazione Russa 7
EU - Europa 6
IR - Iran 6
JP - Giappone 6
BR - Brasile 5
VA - Santa Sede (Città del Vaticano) 5
BG - Bulgaria 4
HU - Ungheria 4
SG - Singapore 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AU - Australia 3
CH - Svizzera 3
CO - Colombia 3
ES - Italia 3
IL - Israele 3
AR - Argentina 2
BD - Bangladesh 2
BZ - Belize 2
CM - Camerun 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
MU - Mauritius 2
VN - Vietnam 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
CL - Cile 1
DK - Danimarca 1
GR - Grecia 1
HK - Hong Kong 1
IE - Irlanda 1
IQ - Iraq 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
PH - Filippine 1
PK - Pakistan 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 6780
Città #
Hangzhou 440
Jacksonville 205
Nürnberg 202
Chandler 173
San Mateo 153
Ann Arbor 144
Nanjing 136
Dearborn 118
Beijing 107
Wilmington 81
Izmir 73
Woodbridge 63
Lawrence 56
Kraków 55
Boston 52
Nanchang 52
Ashburn 51
Cattolica 45
Houston 45
Redwood City 44
Milan 42
Munich 38
Kunming 31
Seattle 31
Shenyang 27
Tianjin 23
Mountain View 22
Hebei 21
Princeton 21
Norwalk 20
Changsha 18
Leawood 17
Redmond 17
Lancaster 16
Guangzhou 15
Los Angeles 15
University Park 15
Fairfield 14
Fremont 13
Jinan 13
Costa Mesa 12
Zhengzhou 12
Augusta 11
Brussels 11
Jiaxing 11
Shanghai 11
Auburn Hills 9
New York 9
Hefei 8
Ningbo 8
Rome 8
San Jose 8
Chicago 7
Renton 7
Andover 6
Cambridge 6
Falls Church 6
Lanzhou 6
Timisoara 6
Verona 6
Buffalo 5
Monza 5
Ottawa 5
Brooklyn 4
Budapest 4
Chongqing 4
Mcallen 4
Old Bridge 4
Rende 4
Sofia 4
Taizhou 4
Albuquerque 3
Amsterdam 3
Changchun 3
Detroit 3
Kocaeli 3
Medellín 3
San Diego 3
Simi Valley 3
Wenzhou 3
Alameda 2
Ardabil 2
Bangalore 2
Baotou 2
Belize City 2
Berlin 2
Bremen 2
Easton 2
Groningen 2
Hanoi 2
Helsinki 2
Indiana 2
Las Vegas 2
Montréal 2
Nagoya 2
Napoli 2
Orange 2
Putian 2
Saint-quentin 2
Sanayi 2
Totale 3006
Nome #
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 297
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 286
Factors associated with mortality in bacteremic patients with haematologic malignancies 275
Factors associated with mortality in bacteremic patients with hematologic malignancies. 274
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy 266
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 188
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. 186
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 184
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. 143
Factors associated with mortality in bacteremic patients with hematologic malignancies. 142
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 139
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 138
High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis caused by staphylococcal small-colony variants 136
Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. 132
Tuberculous spondylodiscitis: epidemiology, clinical features, treatment, and outcome 127
Revised central nervous system neuropenetration-effectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 127
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 125
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 124
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy. 123
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 122
Safety and effectiveness of transvenous lead extraction in octogenarians 117
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy 114
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 109
Bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. 105
Antimicrobial-resistant Gram-negative bacteria in febrile neutropenic patients with cancer: current epidemiology and clinical impact 103
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 101
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 97
Esthesioneuroblastoma in an HIV-1 Infected Patient: Case Report 96
Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae 95
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality. 81
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 81
Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. 79
Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy 79
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 78
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 78
Multidrug-resistant Proteus mirabilis bloodstream infections: risk factors and outcomes 77
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 71
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 68
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 67
Uncommon yeast infections in hematological patients: from diagnosis to treatment 67
Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients 65
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 64
Mortality in patients with early- or late-onset candidaemia 63
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 61
Mortality in patients, with early-or late-onset candidaemia 61
A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality 59
Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study 58
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 58
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 57
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 57
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 57
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 52
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 50
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study 50
Mortality in patients with early- or late-onset candidaemia 49
Mortality in patients with early- or late-onset candidaemia 48
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 47
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 46
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia 46
Epidemiological and clinical features of pyogenic spondylodiscitis. 44
Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey 41
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 40
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 40
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia 39
Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections 35
Characteristics of staphylococcus aureus bacteraemia and predictors of early and late mortality 33
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 30
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study 28
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 27
Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria 27
Isavuconazole-Animal Data and Clinical Data 24
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 23
Therapeutic options for carbapenem-resistant Enterobacteriaceae infections 22
Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital 21
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 21
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 18
When Viruses Meet Fungi: Tackling the Enemies in Hematology 13
Totale 6871
Categoria #
all - tutte 8901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/2018582 0000 7649 4860 1038165100
2018/20191189 44464980 142125 16470 57118179115
2019/20201540 2241407768 159192 15571 112111113118
2020/2021715 75772066 8052 6429 1071511713
2021/2022856 83834748 5239 12140 3863116135
2022/2023560 19122311531 00 00 0000
Totale 6871